Literature DB >> 536454

Mass fragmentographic method for the determination of ketobemidone in plasma.

U Bondesson, P Hartvig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 536454     DOI: 10.1016/s0021-9673(00)80679-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  3 in total

1.  Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone.

Authors:  A Tamsen; U Bondesson; B Dahlström; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

2.  Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.

Authors:  P Anderson; S Arnér; U Bondesson; L O Boréus; P Hartvig
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

3.  Clinical pharmacokinetics and oral bioavailability of ketobemidone.

Authors:  U Bondesson; S Arnér; P Anderson; L O Boréus; P Hartvig
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.